[Bladder lesions due to local administration or ingestion of antiseptic, cytostatic and radioactive compounds].
D000892:Anti-Infective Agents, Urinary / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D003408:Cresols / Q000627:therapeutic use; D003556:Cystitis / Q000139:chemically induced / Q000188:drug therapy; D006801:Humans; D007457:Iodine Radioisotopes / Q000009:adverse effects; D008628:Mercury / Q000009:adverse effects; D011832:Radiation Injuries; D011868:Radioisotopes / Q000009:adverse effects*; D013852:Thiotepa / Q000009:adverse effects; D001743:Urinary Bladder / Q000187:drug effects / Q000528:radiation effects; D001745:Urinary Bladder Diseases / Q000209:etiology*
D000892:Anti-Infective Agents, Urinary; D000970:Antineoplastic Agents; D003408:Cresols; D007457:Iodine Radioisotopes; D011868:Radioisotopes; D013852:Thiotepa; D008628:Mercury
Les lésions vésicales par administration locale ou par ingestion de produits antiseptiques, cytostatiques et radioactifs